National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

136

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03DC03	UNICAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	783,460 L.L
J05AF10	ENTECAVIR ARROW	G	Entecavir - 0.5mg	0.5mg	Tablet, coated	18,701,506 L.L
J05AF10	ENTECAVIR BIOGARAN	G	Entecavir - 0.5mg	0.5mg	Tablet, coated	19,080,319 L.L
N06DX01	MEMANTINE BIOGARAN	G	Memantine HCl - 20mg	20mg	Tablet, coated	2,444,450 L.L
C10AA05	ATORVASTATINE ARROW GENERIQUES	G	Atorvastatin - 10mg	10mg	Tablet, coated	567,102 L.L
C10AA05	ATORVASTATINE ARROW GENERIQUES	G	Atorvastatin - 10mg	10mg	Tablet, coated	567,102 L.L
G03XC01	RALOXIFENE ARROW	G	Raloxifene HCl - 60mg	60mg	Tablet, coated	1,425,817 L.L
C02AB02	ALDOMET	B	Methyldopa - 250mg	250mg	Tablet, coated	644,400 L.L
G04BD06	MICTONORM	B	Propiverine HCl - 15mg	15mg	Tablet, coated	1,261,868 L.L
C02AB02	ALDOMET	B	Methyldopa - 500mg	500mg	Tablet, coated	856,708 L.L
M05BA04	MARVIL 70	G	Alendronate (monosodium trihydrate) - 70mg	70mg	Tablet, coated	1,173,175 L.L
C10AA05	TORVACOL 10	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, coated	1,128,828 L.L
G04BD06	MICTONORM	B	Propiverine HCl - 5mg	5mg	Tablet, coated	1,917,663 L.L
M05BA04	OREK	G	Alendronate - 70mg	70mg	Tablet, coated	2,404,838 L.L
L01EA01	IMATINIB GP PHARM	G	Imatinib - 400mg	400mg	Tablet, coated	26,083,945 L.L
A10BH01	SITAGLIPTINE ARROW	G	Sitagliptin - 100mg	100mg	Tablet, coated	1,154,361 L.L
A10BH01	SITAGLIPTINE ARROW	G	Sitagliptin - 50mg	50mg	Tablet, coated	1,139,578 L.L
M05BA06	ADROMUX	G	Ibandronic acid - 150mg	150mg	Tablet, coated	821,088 L.L
G04BD08	SOLIFENACINE ARROW	G	Solifenacin succinate - 5mg	5mg	Tablet, coated	952,784 L.L
C10AA05	ATORVASTATINE ARROW GENERIQUES	G	Atorvastatin - 20mg	20mg	Tablet, coated	567,102 L.L
C10AA05	ATORVASTATINE ARROW GENERIQUES	G	Atorvastatin - 20mg	20mg	Tablet, coated	567,102 L.L
G04BD08	SOLIFENACINE ARROW	G	Solifenacin succinate - 10mg	10mg	Tablet, coated	952,784 L.L
L01EA01	IMATINIB GP PHARM	G	Imatinib - 100mg	100mg	Tablet, coated	26,083,945 L.L
C10AA05	TORVACOL 20	G	Atorvastatin (calcium) - 20mg	20mg	Tablet, coated	1,128,828 L.L
C09CA01	LOSARTAN BIOGARAN	G	Losartan potassium - 100mg	100mg	Tablet, coated	439,436 L.L
H05BX01	CINACALCET ARROW	BioTech	Cinacalcet - 30mg	30mg	Tablet, coated	L.L
C10AA05	ATORVASTATINE ARROW GENERQUES	G	Atorvastatin - 40mg	40mg	Tablet, coated	564,414 L.L
G04BE03	SILDENAFIL STRAGEN	G	Sildenafil - 20mg	20mg	Tablet, coated	38,048,630 L.L
C10AA05	ATORVASTATINE ARROW GENERQUES	G	Atorvastatin - 40mg	40mg	Tablet, coated	564,414 L.L
L02BB03	BICALUTAMIDE BIOGARAN	G	Bicalutamide - 50mg	50mg	Tablet, coated	4,315,078 L.L

...

136

...